HB 1004 is a broad health care bill that revises Indiana’s Medicaid financing and hospital payment framework, expands reporting requirements for hospitals and nonprofit hospital systems, and adds new disclosure rules for insurers, pharmacy benefit managers, and health plans. A major portion of the bill restructures how Indiana can fund Medicaid disproportionate share hospital payments and state-directed payment programs, including creating new authority for a state directed payment program beginning July 1, 2025, and tying several existing hospital fee and trust fund provisions to that program. The bill also extends the expiration date of the hospital assessment fee chapter from June 30, 2025 to June 30, 2027.
The bill’s impact on state law is substantial. It amends multiple sections of the Indiana Code governing Medicaid indigent care trust funds, hospital assessment fees, Healthy Indiana Plan financing, and disproportionate share hospital payments, while repealing or replacing older definitions and phase-out provisions. It creates new reporting obligations for hospitals and nonprofit hospital systems, including detailed annual financial disclosures, ownership information, and Schedule H filings, and imposes daily civil penalties for late filing. It also requires nonprofit hospital systems and other hospitals to offer direct-to-employer health care arrangements at or below a benchmark tied to 260% of full Medicare, subject to audits and penalties, and directs the Office of Management and Budget to study hospital pricing and physician reimbursement impacts.
The bill also adds several insurance-market transparency provisions. It requires disclosure of insurance producer commissions and related compensation, expands pharmacy benefit manager audit rights and claims-data access for contract holders, requires disclosure of generic drug acquisition cost and rebate information, and mandates reporting on hospital reimbursement changes and their effect on premiums. These provisions affect hospitals, nonprofit hospital systems, insurers, health maintenance organizations, managed care organizations, pharmacy benefit managers, third-party administrators, employers, and state agencies such as the Family and Social Services Administration, the Department of Insurance, and the Department of Health.
The general sentiment reflected in the voting history suggests the bill had majority support but also notable opposition, especially on the Senate floor. It passed the House on third reading 68-26, passed the Senate on third reading 29-19, and then returned to both chambers for conference committee approval, where it again received majority support. However, a Senate amendment failed 13-36, indicating that some proposed changes were not broadly accepted and that the bill’s final form likely reflected compromise on contested issues.
The main points of contention appear to center on hospital payment policy, Medicaid financing, and the new pricing and reporting mandates imposed on hospitals and nonprofit systems. The bill’s requirements for direct-to-employer pricing benchmarks, detailed ownership and financial disclosures, and potential nonprofit-status forfeiture are likely to have drawn concern from hospitals and hospital systems, while supporters likely viewed them as tools to improve affordability, transparency, and accountability. The restructuring of Medicaid hospital funding and the creation of a state-directed payment program also appear to have been significant policy issues, given the bill’s extensive revisions to existing hospital fee and DSH payment statutes.
HB 1004 substantially revises Indiana statutes governing Medicaid hospital financing, disproportionate share hospital payments, hospital assessment fees, and the Healthy Indiana Plan. It creates a new state-directed payment program framework, extends the hospital assessment fee chapter’s expiration date, and ties multiple existing funding mechanisms to federal approval and the new payment structure. The bill also adds new reporting, disclosure, and penalty provisions affecting hospitals, nonprofit hospital systems, insurers, health maintenance organizations, pharmacy benefit managers, third-party administrators, and managed care organizations, while authorizing studies and rulemaking by state agencies.
The bill appears to have been generally supported by legislative majorities, but not without meaningful opposition. It passed both chambers on third reading and was ultimately approved in conference committee form, yet a Senate amendment failed decisively, suggesting that some members objected to specific policy details. Overall, the vote pattern indicates broad enough support to enact the bill, alongside persistent concern about its hospital-payment reforms and regulatory burdens.
The most notable contention likely involved the bill’s hospital pricing and Medicaid financing provisions. Hospitals and nonprofit hospital systems may have opposed the new benchmark pricing requirements, expanded reporting obligations, and the possibility of penalties or loss of nonprofit tax status, while supporters likely argued these measures would improve affordability and transparency. Another likely flashpoint was the shift to a state-directed payment program and the reworking of disproportionate share and fee-based funding streams, which affect how money flows among hospitals, managed care organizations, and the state Medicaid program.